US Patent 11401286 Heteroaryl inhibitors of PDE4
Patent 11401286 was granted and assigned to Tetra Therapeutics on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
A. Samuel Vellekoop0
Donna L. Romero0
Joel R. Walker0
Lei Zhu0
Mark E. Gurney0
Robert Campbell0
Timothy J. Hagen0
Xuesheng Mo0
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114012860
Date of Patent
August 2, 2022
0Patent Application Number
167817480
Date Filed
February 4, 2020
0Patent Citations
Patent Primary Examiner
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+251 characters)
US Patent 11401286 Heteroaryl inhibitors of PDE4
Article
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11401286
Date of patent
August 2, 2022
Patent application number
16781748
Date Filed
February 4, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11401286 Heteroaryl inhibitors of PDE4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.